Enzo Biochem Beheer
Beheer criteriumcontroles 0/4
Enzo Biochem's CEO is Kara Cannon, appointed in Sep 2023, has a tenure of 1.17 years. total yearly compensation is $1.22M, comprised of 24.4% salary and 75.6% bonuses, including company stock and options. directly owns 0.53% of the company’s shares, worth $311.29K. The average tenure of the management team and the board of directors is 1.2 years and 1.1 years respectively.
Belangrijke informatie
Kara Cannon
Algemeen directeur
US$1.2m
Totale compensatie
Percentage CEO-salaris | 24.4% |
Dienstverband CEO | 1.2yrs |
Eigendom CEO | 0.5% |
Management gemiddelde ambtstermijn | 1.2yrs |
Gemiddelde ambtstermijn bestuur | 1.1yrs |
Recente managementupdates
Recent updates
Analyse CEO-vergoeding
Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
---|---|---|---|
Jul 31 2024 | n/a | n/a | -US$10m |
Apr 30 2024 | n/a | n/a | -US$18m |
Jan 31 2024 | n/a | n/a | -US$23m |
Oct 31 2023 | n/a | n/a | -US$25m |
Jul 31 2023 | US$1m | US$299k | -US$25m |
Apr 30 2023 | n/a | n/a | -US$27m |
Jan 31 2023 | n/a | n/a | -US$24m |
Oct 31 2022 | n/a | n/a | -US$23m |
Jul 31 2022 | US$769k | US$270k | -US$20m |
Apr 30 2022 | n/a | n/a | -US$7m |
Jan 31 2022 | n/a | n/a | US$300k |
Oct 31 2021 | n/a | n/a | US$5m |
Jul 31 2021 | US$426k | US$265k | US$8m |
Apr 30 2021 | n/a | n/a | US$1m |
Jan 31 2021 | n/a | n/a | -US$11m |
Oct 31 2020 | n/a | n/a | -US$21m |
Jul 31 2020 | US$371k | US$220k | -US$29m |
Apr 30 2020 | n/a | n/a | -US$31m |
Jan 31 2020 | n/a | n/a | US$2m |
Oct 31 2019 | n/a | n/a | US$822k |
Jul 31 2019 | US$379k | US$220k | US$2m |
Apr 30 2019 | n/a | n/a | US$2m |
Jan 31 2019 | n/a | n/a | -US$23m |
Oct 31 2018 | n/a | n/a | -US$16m |
Jul 31 2018 | US$342k | US$198k | -US$10m |
Compensatie versus markt: Kara's total compensation ($USD1.22M) is above average for companies of similar size in the UK market ($USD369.71K).
Compensatie versus inkomsten: Kara's compensation has increased whilst the company is unprofitable.
CEO
Kara Cannon (55 yo)
1.2yrs
Tenure
US$1,221,793
Compensatie
Ms. Kara Cannon serves as Chief Executive Officer at Enzo Biochem, Inc. from January 31, 2024 and serves as its Director from 2024 and served as its Interim CEO since September 5, 2023 until January 31, 20...
Leiderschapsteam
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
CEO & Director | 1.2yrs | US$1.22m | 0.53% $ 311.3k | |
Chief Financial Officer | 2yrs | US$453.56k | 0.037% $ 21.9k | |
General Counsel | less than a year | geen gegevens | geen gegevens |
1.2yrs
Gemiddelde duur
53yo
Gemiddelde leeftijd
Ervaren management: 0IHV's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
CEO & Director | less than a year | US$1.22m | 0.53% $ 311.3k | |
Independent Chairperson of the Board | 1.1yrs | geen gegevens | 0.034% $ 20.0k | |
Independent Director | 2.8yrs | US$195.00k | 8.07% $ 4.8m |
1.1yrs
Gemiddelde duur
55yo
Gemiddelde leeftijd
Ervaren bestuur: 0IHV's board of directors are not considered experienced ( 1.1 years average tenure), which suggests a new board.